Connected commercial planning using Anaplan: Gross-to-Net (GTN)


Gross-to-net adjustments have doubled in the past seven years and are squeezing profit margins as distance grows between drug list prices and their net prices after rebates and other reductions. A 1% improvement in GTN can mean millions to the bottom line.

Technology partners


Anaplan is a cloud-native enterprise SaaS company that empowers global organizations to orchestrate business performance and execute digital transformation with confidence and agility. 2021 AMER Partner of the Year


Gold Partner




years of partnership


Our clients include pharmaceutical companies, big or small, focusing on branded, specialty, and generic segments. Being able to understand, explain, and accurately forecast GTN adjustments is critical to the finance function of commercial pharmaceutical organizations.


In one centralized solution, capture the impact of market events to forecast in-market volumes; model pricing changes by brand and SKU; perform pre-/post-deal analytics and forecast and measure contract performance; incorporate rebate assumptions; and forecast channel mix and rebates by channel across Commercial, Part D, and Medicaid. Quickly apply changes to methodologies for forecasting GTN.

Key results

Improve predictability and profitability in the GTN process
Reduce human error from spreadsheets and manual data movement
Access real-time views of the business, from aggregate to high-resolution


Simplify gross-to-net complications and confidently model all assumptions around distributor agreements, complex contract terms, and all rebates, chargebacks, and deductions.

Share this key play


Ready for your own success story?

Get in touch with our team of experts.

I acknowledge having read the privacy policy and I consent to the processing of my personal data.

Keyrus collects and processes the data you fill out in this form in order to respond to your request. The fields marked with an asterisk must be filled in for your request to be processed. This processing is based on your consent, which you may withdraw at any time. To learn more about how we manage your personal data and to exercise your rights, please refer to the Privacy Policy. By clicking on Submit, I acknowledge that I have read and accepted the legal notice and the general terms of use of the site.